Zoledronic acid injection (Reclast, Novartis) has been approved as the first therapy to prevent postmenopausal osteoporosis for two years with a single dose.
In a study involving more than 500 postmenopausal women with osteopenia, a single infusion significantly increased bone mineral density at two years compared with placebo.

Regardless of their personal opinions or religious beliefs about the morning-after
A new technique for reducing the burden of ovarian tumors in mice might be available for testing in humans within 18 to 24 months.
Merck’s Gardasil vaccine is now indicated for the prevention of genital warts (condyloma acuminata) caused by human 